Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joshua June (NPI 1205147873)

Field	Value
Entity Type	Individual
Organization	Joshua June
Address	4052 Legacy Park Way
City	Lansing
State	MI
ZIP	48911
Taxonomy	Rheumatology Physician
NPI Enumerated	June 28, 2010

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider’s public‑payer activity is effectively single‑payer: lifetime Medicare revenue is $1.5M and there is no Medicaid billing on file, so Medicaid does not appear to contribute to the practice’s revenue mix. The provider’s NPI was enumerated 2010-06-28 (~16 years ago), indicating roughly 16 years of Medicare participation and an established billing history with public payers.

Revenue is highly concentrated in a small set of drugs: the precomputed top three Medicare codes account for 52.3% of this provider’s total Medicare revenue. Those top three are J0490 ($310.9K revenue, 21.0% of Medicare revenue), J0129 ($255.8K revenue, 17.3%), and J1602 ($207.5K revenue, 14.0%), signaling a heavy dependence on a few high‑value J‑codes.

The code mix indicates the practice operates a biologic infusion/medication‑administration service line consistent with its Rheumatology Physician taxonomy: the revenue leaders J0490, J0129, and J1602 are biologic injections frequently used to treat autoimmune and inflammatory conditions. Additional on‑site administration and infusion codes in the top‑25 (96413, 96365, 96372, 96415) further support that medications are often given in clinic rather than solely as self‑administered pharmacy fills.

Competitive standing for the top biologic codes is mixed: J0490 ranks #7 of 39 providers nationally (84th percentile; typical, unremarkable volume for this code), J0129 ranks #653 of 1221 (46th percentile; typical, unremarkable volume for this code), and J1602 ranks #285 of 1041 (73th percentile; typical, unremarkable volume for this code). In aggregate, these ranks suggest the provider has a meaningful presence in select biologic therapies but is not a dominant national outlier across all J‑codes.

The provider is an outlier on E&M coding: 99214 appears as 1.1K claims with $95.7K revenue (6.5% of Medicare revenue) and ranks #9283 of 479517 providers nationally (98th percentile; extreme outlier, far above typical national volume for this code). This unusually high volume of moderate‑level established‑patient visits may reflect a large or clinically complex Medicare panel, heavy chronic disease follow‑up, or practice-level coding patterns that differ from typical peers.

Ancillary musculoskeletal services are also present: bone density and fracture‑risk assessment codes appear on the top‑25 list (77085 — 173 claims, $8.5K revenue, 0.6% of Medicare revenue; 77089 — 273 claims, $7.4K revenue, 0.5%; 77080 — 109 claims, $3.9K revenue, 0.3%). Those entries indicate on‑site DXA and trabecular bone score capacity, supporting integrated osteoporosis assessment alongside rheumatologic care.

Infusion and chemotherapy administration activity is evident across multiple CPT codes (96413 — 210 claims, $19.5K revenue, 1.3%; 96365 — 258 claims, $11.6K revenue, 0.8%; 96372 — 453 claims, $4.5K revenue, 0.3%; 96415 — 207 claims, $4.3K revenue, 0.3%). Notably, 96372 ranks #1947 of 58224 providers nationally (97th percentile; notably above typical national volume for this code), indicating higher-than‑typical use of direct injection administration services relative to peers.

From a payer or network strategy perspective, the combination of a $1.5M Medicare footprint, zero Medicaid billing on file, and 52.3% of Medicare revenue coming from three biologic J‑codes creates both leverage and concentration risk. Payers should view this provider as a specialized infusion/biologic therapy source for rheumatology patients, but also recognize sensitivity to policy or reimbursement changes that affect those specific high‑revenue drug codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

34 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0490	Injection, belimumab, 10 mg	7,970	$40	$310.9K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	7,750	$30	$255.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	20,750	$10	$207.5K
J0897	Injection, denosumab, 1 mg	10,680	$20	$192.2K
J9312	Injection, rituximab, 10 mg	2,150	$60	$137.6K
J3111	Injection, romosozumab-aqqg, 1 mg	12,390	$10	$99.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,090	$90	$95.7K
J3262	Injection, tocilizumab, 1 mg	15,000	$10	$75K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	390	$60	$24.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	210	$90	$19.5K

Showing 1–10 of 34

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Joshua June — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

34 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	9	20	7,700	$30	$285.5K
J0490	1	10	5,700	$40	$222.2K
J3262	7	10	26,240	$1	$191.1K
J1602	4	20	14,430	$10	$153.5K
J9312	1	10	2,150	$60	$136.8K
J3111	7	10	13,020	$10	$126.1K
J0897	11	170	2,460	$20	$69.1K
96413	51	170	120	$100	$16.1K
99214	101	15,470	80	$80	$11.4K
99213	837	14,810	60	$60	$6.6K

Showing 1–10 of 34

Related Providers

Other providers that share a Tax Identification Number (TIN) with Joshua June, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Joshua P June Do	MI	Rheumatology Physician	$0	$7M
Mhd Iyad Alshwaf	MI	Rheumatology Physician	$1.2M	$0
Amy Trinh	MI	Family Medicine Physician	$334.5K	$0
John Kolstoe	MN	Rheumatology Physician	$84.1K	$0
Mark Braden	MI	Neuromusculoskeletal Medicine & OMM Physician	$34.2K	$0

Nearby Providers

Other providers in the same ZIP code as Joshua June, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Home Care Alternatives	MI	Home Health Agency	$0	$15.2M
County Of Ingham	MI	Federally Qualified Health Center (FQHC)	$0	$8.6M
Capital Internal Medicine Associates P.C.	MI	Internal Medicine Physician	$0	$7.9M
Dental Dreams PLLC	MI	General Practice Dentistry	$0	$6.4M
D2 Dental Of Michigan	MI	Dentist	$0	$6M
Richard Ferro	MI	Interventional Pain Medicine Physician	$143.2K	$0
Amit Ghose	MI	Internal Medicine Physician	$94.6K	$0
Michael Kowalczyk	MI	Internal Medicine Physician	$92K	$0
Urvish Shah	MI	Gastroenterology Physician	$86K	$0
Roy Meland	MI	Psychiatry Physician	$78.1K	$0

Joshua June — Billing Profile & Reimbursement Data

Sign up for Joshua June — Billing Profile & Reimbursement Data policy alerts

Joshua June — Billing Profile & Reimbursement Data

Sign up for Joshua June — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References